Use of serial C-reactive protein measurements for determination of the length of empiric antibiotic therapy in suspected neonatal sepsis

Iranian Journal of Medical Sciences

Volumn 29, Issue 1, 2004, Pages 31-35

  Khashabi, J ^a,b   Karamiyar, M ^a   Taghinejhad, H ^a   Shirazi, M ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Antibiotic therapy; C reactive protein; Neonatal Infection; Neonatal sepsis

Indexed keywords

AMPICILLIN; C REACTIVE PROTEIN; GENTAMICIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; EMPIRICISM; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SEPSIS; PATIENT MONITORING; PNEUMONIA; PRACTICE GUIDELINE; PREDICTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 7044264878     PISSN: 02530716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Escobar GJ, Zukin T, Usatin MS, et al: Early discontinuation of antibiotic treatment in newborns admitted to rule out sepsis, a decision rule. Pediatr Infect Dis J 1994;13:860-66.
2. Eichenwald E C: Perinatally transmitted neonatal bacterial infections. Infect Dis clin of North Am 1997;11:223-39.
3. Sormunen P, Kallio M J, Kilpi T, et al: C-reactive protein is useful in distinguishing gram-negative bacterial meningitis from viral meningitis in children. J Pediatr 1999;134:725-29.
4. Weinberg G, Powell K: Laboratory aids for diagnosis of neonatal sepsis. In: Remington J, KleinJ, eds: Infectious Disease of Fetus and Newborns Infant. 5th ed. Philadelphia: Saunders, 2001:1327-44.
5. Shine B, Gould J, Campbell C, et al: Serum C- reactive protein in normal and infected neonates. Clin Chim Acta 1985;148:97-103.
6. Ehl S, Gering B, Bartmann P, et al: C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected bacterial infection. Pediatrics 1997;99:216-21.
7. Franz A R, Steinbach G, Korn M, et al: Reduction of unnecessary antibiotic therapy in newborn infants using interleukin - 8 and C - reactive protein as markers of bacterial infection. Pediatrics 1999; 104:447-53.
8. Bomela H N, Ballot D E, Cory B J, et al: C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis. Pediatr Inf Dis J 2000;19:531-35.
9. Pourcyrous M, Bada HS, Kornes SB, et al: Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993;92: 431-435.
10. Gerdes J: Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatal 1991;18:361-81.
11. Philip A G: Acute phase proteins in neonatal infection. J Pediatr 1984;105:940-42.
12. Philip A G S: Sepsis + C-reactive protein. Pediatrics 1994;93:693-94.
13. Mathers NJ, Pohlandt F: Diagnostic audit of C-reactive protein in neonatal infection. Eur J Pediatr 1987;146:147-51.
14. Hindocha P. Campbell C, Gould J: Serial study of C reactive protein in neonatal septicemia. Arch Dis Child 1984;59:435-38.
15. Chan D K L, Ho L Y: Usefulness of C-reactive protein in the Diagnosis of Neonatal Sepsis. Singapore Med J 1997;38:252-55.
16. Samuel G: Neonatal sepsis: In: Behrman R E, Kliegman R M, Jenson H B. Nelson Textbook of Pediatrics. 15th ed. Philadelphia: Saunders, 1996:528-30.
17. Stoll B: Neonatal infections: a global perspective. In: Remington J, Klein J, eds: Infectious diseases of the fetus and newborn infants. 5th ed. Philadelphia: Saunders, 2001: 139-167.
18. Pinchero M E. Todd J: Detection of neonatal bacterium. J Pediatr 1979;94:958-60.
19. Jaswal RS, Kaushal RK, Goel A, et al: Role of C-Reactive protein in deciding duration of antibiotic therapy in neonatal septicemia. Indian Pediatr 2003;40:880-83.
20. Hengst J M: The role of C-reactive protein in the evaluation and management of infants of suspected sepsis. Adv Neonatal Care 2003;3: 3-13.
21. Jaye D, Waites K: Clinical applications of C-reactive proteins. Pediatr Infect Dis 1997;16:735-46.
22. Kawamura M, Nishida H: The usefulness of serial C-reactive proteins in managing neonatal infection. Acta Pediatr 1995;84:10-13.
23. Du Clos TW: Function of C- reactive protein. Ann Med 2002;32:274-78.
24. Ng PC, Cheng SH, Chuei K M, et al: Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C- reactive protein in preterme very low birth weight infants. Arch Dis Child 1997;77:221-27.
25. Philip A, Mills P: Use of C -reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well -baby nursery. Pediatrics. 2000. ttp://www.pediatrics.org/cgi//content/full/10 6(1);E4.
26. Philip AG: Response of C-reactive protein in neonatal group B streptococcal infection. Pediatr Infect Dis J 1985;4:145-48.
27. Blomendahl J, Janas M, Laine S, et al: Comparison of procalcitonin with CRP and differential white blood cell count for diagnosis of culture proven neonatal sepsis. Scand J Infect Dis 2002;34: 620-22.
28. Isaacman DJ, Burke BL: Utility of C- reactive protein for detection of occult bacterial infection in children. Arch Pediatr Adolesc Med 2002;156:905-9.
29. Appenzeller C, Ammann R, Duppenthaler A, et al: Serum C- reactive protein in children with adenovirus infection. Swiss Med Wkly 2002;132:345-50.
30. Posen R, deLemos R: C-reactive proteins levels in the extremely premature infants: case studies and literature review. J Perinatol 1998;18: 138-41.